Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 767

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 767
---
 in any number of identical counterparts, each of which, for all purposes, is to be deemed an original, and all of which constitute, collectively, one and the same Amendment. Signatures transmitted by electronic means such as email or facsimile shall have the same legal effect as an original signature hereto.

<div align='center'>[Signature page to follow.]

E-31</div>

TABLE OF CONTENTS

IN WITNESS WHEREOF, this Fourth Amendment to Subscription Agreement has been duly executed and delivered by each of the Parties as of the date first above written.

#### IRIS

#### Iris Acquisition Corp
By:

/s/ Sumit Mehta

Name: Sumit Mehta 
 Title: Chief Executive Officer

### PARENTCO

#### Iris Parent Holding Corp.
By:

/s/ Chris Kim

Name: Chris Kim 
 Title: CEO, Secretary and Treasurer

### SUBSCRIBER

#### Ewon Comfortech Co., Ltd.
By:

/s/ Kyeong Hoon Lee

Name: Kyeong Hoon Lee 
 Title: President

### LIMINATUS

#### Liminatus Pharma, LLC
By:

/s/ Chris Kim

Name: Chris Kim 
 Title: CEO, Secretary and Treasurer

<div align='center'>Signature Page to Fourth Amendment to Subscription Agreement

E-32</div>

TABLE OF CONTENTS

### FIFTH AMENDMENT TO SUBSCRIPTION AGREEMENT
This Fifth Amendment to Subscription Agreement (this “

#### Amendment
”) is entered into as of October 31, 2024, by and among Iris Acquisition Corp, a Delaware corporation (“

#### Iris
”), Iris Parent Holding Corp., a Delaware corporation (“

#### ParentCo
”), Ewon Comfortech Co., Ltd., a South Korean company (“

#### Subscriber
”), and Liminatus Pharma, LLC, a Delaware limited liability company (“

#### Liminatus
”). Each of Iris, ParentCo, Subscriber and Liminatus is also referred to herein as a “

#### Party
” and, collectively, the “

#### Parties
”.

### RECITALS
WHEREAS, Iris, ParentCo and Subscriber entered into that certain Subscription Agreement, dated November 28, 2022 (the “

#### Subscription Agreement
”);

WHEREAS, the Parties previously entered into that certain Amendment to Subscription Agreement, dated August 14, 2023, to among other things, extend the Closing Date (as defined in the Subscription Agreement) to March 9, 2024, and